Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest Additions

Prominent colorectal surgeon Michael Weinstein, MD, FACS, discusses the current and future role of open and laparoscopic procedures. Sponsored by The Doctor’s Channel
Nicole Artz, MD, a hospitalist and Assistant Professor of Medicine at the University of Chicago Hospital, discusses new protocols to control glucose levels in the inpatient setting. References and Resources Umpierrez GE, Smiley D, Zisman A, Prieto...
Prominent colorectal surgeon Norman Sohn, MD, FACS, MBA, discusses a novel timesaving colonoscopy prep technique, the Colonoscopic Colon Enema (CCE), that he uses when patients arrive for their procedure poorly prepped. This technique allows you to...
Lisa Shah, MD, Clinical Associate of Medicine, Section of General Internal Medicine, University of Chicago, describes a clinical trial employing the Contemplation Ladder to assess Cardiology inpatients readiness to quit smoking. Patient follow-up and...
General Surgeon, Les Edrich, MD provides some insight toward negotiating the delicate balance of providing information, treatment options, and an opinion regarding the best course of treatment while respecting the potential vulnerability of the patient...
Lisa Shah, MD, Clinical Associate of Medicine, Section of General Internal Medicine, The University of Chicago describes The Contemplation Ladder – a one to ten scale used as a measure of a smoker’s readiness to quit. References Biener L, Abrams...
Les Edrich, MD, a general surgeon from Long Beach, California, discusses the concept of a two-tiered medical system and whether it would have an impact on quality of care. Sponsored by The Doctor’s Channel
Les Edrich, MD, a general surgeon from Long Beach, California, provides an interesting look at reimbursement with the Medicaid program. Sponsored by The Doctor’s Channel
General Surgeon, Les Edrich, MD discusses an alternative to Veress needle entry during laparoscopic cholecystectomy that may help avoid injury to the intrabdominal organs and the potential resulting litigation. Sponsored by The Doctor’s Channel

Fails to alleviate moderate persistent asthma symptoms

Mepolizumab Fails in a Phase II Trial

Mepolizumab, an IL-5 inhibitor, failed to alleviate moderate persistent asthma symptoms in a phase II trial of patients resistant to corticosteroids. References and Resources Flood-Page P, Swenson C, Faiferman I. A Study to Evaluate Safety and...